Clinical Trials in Rendsburg, Schleswig-Holstein
2 recruiting
Showing 1–2 of 2 trials
Recruiting
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Breast Neoplasms
Novartis Pharmaceuticals3,250 enrolled267 locationsNCT06830720
Recruiting
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Moderate to Severe Rheumatoid Arthritis
AbbVie678 enrolled53 locationsNCT06712628